Immunocompromised Hosts: Immunopharmacology of Modern Antifungals
نویسندگان
چکیده
منابع مشابه
Immunopharmacology of Modern Antifungals
In addition to their in vitro inhibitory and fungicidal effects, modern antifungal agents interact in vivo with host immune functions involved in defense against fungal pathogens. The nature of such interactions is diverse and depends on the drug, the immunological status of the host, and the fungal pathogen. Given the prominent role of the host’s immune response in controlling invasive fungal ...
متن کاملAdenoviruses in immunocompromised hosts.
SUMMARY The number of patients with acquired immunodeficiency has grown steadily as a result of both a larger number of patients receiving solid organ and hematopoietic stem cell transplants and their longer survival times. The use of newer, more potent immunosuppressive regimens has increased the frequency of severe adenovirus infections. Human adenoviruses are a large group of viruses, repres...
متن کاملSepsis in immunocompromised hosts.
Over the past 20–30 years there has been a dramatic increase in the number of people living with immunosuppression. Cancer chemotherapy and the treatment of haematological disease transiently put people at risk, while the immunosuppression required for solid organ transplants and for immunemediated diseases, such as systemic lupus erythematosus, is more prolonged. In addition to these iatrogeni...
متن کاملMicroneedle patch for immunization of immunocompromised hosts
Influenza virus is a major cause of morbidity and mortality particularly in the immunocompromised host. When compared to the general population, influenzarelated hospitalization rates are four times higher and mortality ten times higher in patients with cancer [1]. The Infectious Diseases Society of America (IDSA) recommends the administration of inactivated influenza vaccine (IIV) annually to ...
متن کاملTransfusion-acquired HIV infection among immunocompromised hosts.
This survey suggests that HIV infection in immunocompromised hosts is characterized by a high attack rate, short incubation time to clinical sequelae, and WB and RIP seropositivity which may precede evidence of antibodies by ELISA by weeks or months. The functional properties of patients' serum antibodies, such as neutralizing activity against HIV in vitro, may correlate with clinical course.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2008
ISSN: 1058-4838,1537-6591
DOI: 10.1086/589290